Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

When Chad Mirkin, PhD, asked his graduate students to run a “Friday afternoon experiment” nearly 20 years ago, he wasn’t expecting to affect cancer treatment. He simply wanted to see what would happen ...

The FDA is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, the U.S. agency said the drug helps children and adults who cannot get enough folate into ...

In this article, we will list the 5 Most Buzzing Stocks to Buy with the Highest Upside Potential. Please visit 11 Most ...

Scientists have mapped the genetics of cancer in cats for the first time at scale, uncovering major overlaps with human cancers. Key mutations—like those linked to breast cancer—appear in both species ...

A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare and Medicare Advantage.

Meagan Johnson recently spent four days calling dozens of pharmacies around Austin, Texas, trying to fill a prescription for ...

Pharmacy benefit managers (PBMs) have used market leverage to demand rebates, which can lead drug manufacturers to increase sticker prices.

Pharmacists have urged Wes Streeting to stockpile medicines that may run out because of Iran’s blockade on the Strait of ...

Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz ...

Last year, President Donald Trump told pregnant women not to take Tylenol as he promoted unproven ties between the fever reducer and autism and touted an old generic drug as a treatment for the ...

Merck & Co., Inc. (NYSE:MRK) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.